Arotinolol is a pharmaceutical raw material that functions as a mixed alpha/beta adrenoceptor blocking agent and also exhibits beta-3 receptor agonist activity. It was first described in the scientific literature in 1979 as a beta-adrenergic blocking and antiarrhythmic compound.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 41287-43-8
Alfacalcidol
pharmaceutical raw material
(RS)-etodolac
pharmaceutical raw material
Polymyxin B1
pharmaceutical raw material
Cyproheptadine hydrochloride hydrate
pharmaceutical raw material
7-chloro-4-[5-(2-sulfosulfanylethylamino)pentoxy]quinoline
CKQHXOCXLJZGSX-UHFFFAOYSA-N
C1=CC2=C(C=CN=C2C=C1Cl)OCCCCCNCCSS(=O)(=O)O